About the Research Group

Mission

• Designs, develops, implements, and monitors chemoprevention research efforts in the areas of lung and head and neck cancers.
• Implements research through clinical trials screening, testing, and validating new technologies that identify premalignant lesions.
• Monitors clinical trials that develop agents using measures of efficacy that include modulation of surrogate endpoint biomarkers or cancer incidence reduction.
• Interacts and communicates with extramural and intramural investigators in other NCI divisions and organizations of the National Cancer Program.